Tengion has named Scott Flora to its board of directors. Flora brings to Tengion more than 20 years of experience building and managing successful wound healing and surgical device businesses.  He most recently served as global business unit president of surgical devices at Covidien.

"We are excited to welcome Scott with his extensive industry experience and expertise to Tengion's Board. As we continue to advance our regenerative medicine product candidates, his perspectives on strategic collaborations, product development, and new product launches in the medical and surgical device arenas will be invaluable resources for our Board and the Company," said David Scheer, chairman of the Tengion board of directors.

Tengion also announced today that Gary Kurtzman, M.D., managing director, Life Sciences Group at Safeguard Scientifics is stepping down from the Tengion board of directors after three years of service.